Resource Roundup: Integrative Interventions for Depression and Anxiety

Advising Patients About Ketamine Use in Clinical Practice

The psychedelic drug ketamine has received much media attention lately. But how much do integrative practitioners know about this medication? And how does its use compare to psilocybin, a natural psychedelic substance? 

Regarding ketamine, a recent systematic review and meta-analysis of 49 randomized clinical trials published in The Lancet found ketamine to be effective at treating depression, especially severe depression. In particular, the analysis found a moderate to high response within 24 hours of treatment, with more frequent, higher doses outperforming single, lower-dose treatments.

To read more, click here.